Financial Contrast: Carmell (NASDAQ:CTCX) and Assure (NASDAQ:IONM)

Profitability

This table compares Carmell and Assure’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Carmell	N/A	-217.50%	-50.22%
Assure	-25,178.32%	N/A	-249.78%

Risk and Volatility

Carmell has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Comparatively, Assure has a beta of 185.75, suggesting that its stock price is 18,475% more volatile than the S&P 500.

Institutional & Insider Ownership

24.2% of Carmell shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 29.0% of Carmell shares are owned by company insiders. Comparatively, 3.8% of Assure shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Carmell and Assure”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carmell	$32,839.00	1,801.55	-$15.44 million	N/A	N/A
Assure	$149,000.00	1.01	-$26.08 million	N/A	N/A

Carmell has higher earnings, but lower revenue than Assure.

Summary

Carmell beats Assure on 6 of the 9 factors compared between the two stocks.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

About Assure

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.